2-Amino-3-(4-chloro-benzoyl)-6-(2-phenyleth-1-yl)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2-Amino-3-(4-chloro-benzoyl)-6-(2-phenyleth-1-yl)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine
• 英文别名: [2-amino-6-(2-phenylethyl)-5,7-dihydro-4H-thieno[2,3-c]pyridin-3-yl]-(4-chlorophenyl)methanone
• 化学式: C₂₂H₂₁ClN₂OS
• 分子量: 396.941
• InChiKey: VMIQRWAFDLFQEJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.6
• 重原子数：
  27
• 可旋转键数：
  5
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  74.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  2'-溴-4-氯苯乙酮 在 吗啉 、 sulfur 作用下， 以 乙醇 、 水 为溶剂， 反应 3.0h， 生成 2-Amino-3-(4-chloro-benzoyl)-6-(2-phenyleth-1-yl)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine
  参考文献：
  名称：

  Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A1-adenosine receptor

  摘要：

  New derivatives of PD 81,723, an allosteric enhancer of agonist binding to the A(1)-adenosine receptor, have been synthesized and evaluated in an intact cell assay. Compounds 3a, 3o and 3p appeared to be more potent than PD 81.723 and at a concentration of 0.1 mu M caused significant reductions of cAMP content of CHO cells expressing the human A(1)-adenosine receptor. Compounds 4e and 4o appeared to be allosteric enhancers at a low concentration and antagonists at a higher concentration, whereas compounds 3c, 3g, 3s and ill appeared to be weak antagonists that are also allosteric enhancers at the: higher concentration of 10 mu M. (C) 2000 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(00)00379-6

文献信息

• Allosteric adenosine receptor modulators
  申请人：King Pharmaceuticals Research and Development, Inc.

  公开号：EP1671973A2

  公开（公告）日：2006-06-21

  The present invention relates to compounds of formulas (IA, IB and IC), the preparation thereof, pharmaceutical formulations thereof, and their use in medicine as allosteric receptor modulators for uses including protection against hypoxia and ischemia induced injury and treatment of adenosine-sensitive cardiac arrhythmias.

  本发明涉及式（IA、IB 和 IC）化合物、其制备方法、其药物制剂及其作为异位受体调节剂在医学中的用途，其用途包括保护免受缺氧和缺血引起的损伤以及治疗腺苷敏感性心律失常。
• Methods and formulations for increasing the affinity of a1 adenosine receptor ligands for the a1 adenosine receptor
  申请人：——

  公开号：US20040121406A1

  公开（公告）日：2004-06-24

  Glycolipids are useful for enhancing the affinity of A 1 adenosine receptor ligands for the A 1 adenosine receptor. Glycolipids are accordingly useful in diagnostic and therapeutic methods that require the delivery or administration of A 1 adenosine ligands.

  糖脂有助于增强 A 1 腺苷受体配体对 A 1 腺苷受体的亲和力。因此，糖脂可用于诊断和治疗方法，这些方法需要输送或施用 A1 1 腺苷配体。
• ALLOSTERIC ADENOSINE RECEPTOR MODULATORS
  申请人：Medco Research, Inc.

  公开号：EP1025106A2

  公开（公告）日：2000-08-09
• EP1390740A4
  申请人：——

  公开号：EP1390740A4

  公开（公告）日：2007-04-04
• METHODS AND FORMULATIONS FOR INCREASING THE AFFINITY OF A 1? ADENOSINE RECEPTOR LIGANDS FOR THE A 1? ADENOSINE RECEPTOR
  申请人：Endacea, Inc.

  公开号：EP1390740A1

  公开（公告）日：2004-02-25